Patents Assigned to Synvivia, Inc.
  • ENGINEERED CYCLIC PEPTIDES FOR ENHANCING VIRAL PRODUCTION
    Publication number: 20230416307
    Abstract: The present disclosure provides methods and compositions for production of recombinant viral vectors, such as adeno-associated virus (AAV) vectors or lentiviral vectors, in host cells using engineered cyclic peptides that increase viral titer and transduction efficiency of viral vector compositions. The present disclosure also provides methods for selecting genetically encoded, endogenously expressed cyclic peptides that enhance viral vector manufacturability.
    Type: Application
    Filed: June 22, 2023
    Publication date: December 28, 2023
    Applicant: Synvivia, Inc.
    Inventors: Gabriel Lopez, Charlie Huang